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A pproximately 15% of all clinically recognized pregnancies end in miscarriage during the first 
trimester [1 , 2].  The most common cause of first tri-
mester pregnancy loss is fetal chromosomal abnormali-
ties [3].  The American Society for Reproductive Medicine 
(ASRM) defines recurrent pregnancy loss (RPL) as the 
occurrence of two or more consecutive pregnancy losses 
[4].  The causes of RPL include genetic,  anatomic,  
endocrine,  immunologic,  and environmental factors 
[6-8].  For the estimation of the risk of further miscar-
riage,  individuals who experience RPL are examined 
for congenital uterine malformation,  coagulation factor 
anomalies,  antiphospholipid antibodies,  thyroid dys-
function,  and impaired glucose tolerance,  and they are 
managed accordingly.
Up to 50% of RPL cases do not have a clearly defined 
etiology [5].  Sixty percent of patients who have had two 
miscarriages have no maternal risk factors for RPL [6].  
In such cases,  miscarriages may be caused by recurrent 
chromosomal abnormalities.  Identifying the chromo-
somal profile of the miscarried embryo is important in 
the selection of a treatment strategy for the next preg-
nancy [5],  particularly for patients with RPL.  In RPL 
cases at our institution we therefore perform a chromo-
somal analysis using chorionic villus sampling,  with the 
Acta Med.  Okayama,  2018
Vol.  72,  No.  1,  pp.  61-66
CopyrightⒸ 2018 by Okayama University Medical School.
http ://escholarship.lib.okayama-u.ac.jp/amo/Original Article
Slow Fetal Heart Rate before Miscarriage in the Early First Trimester 
Predicts Fetal Aneuploidy in Women with Recurrent Pregnancy Loss
Ai Sakamotoa＊,  Yasuhiko Kamadaa,  Kotaro Kuboa,  Toru Hasegawaa,   
Sayoko Kotania,  Mikiya Nakatsukab,  and Yuji Hiramatsua
aDepartment of Obstetrics and Gynecology,  Okayama University Graduate Schools of Medicine,   
Dentistry and Pharmaceutical Sciences,  bGraduate School of Health Sciences,  Okayama University,  Okayama 700-8558,  Japan
Establishing whether miscarriages result from fetal aneuploidy or other factors is important for treating recur-
rent pregnancy loss.  We examined the relationship between fetal heart rate (FHR) before miscarriage in the 
early first trimester and fetal karyotype,  analyzing 223 pregnant women with recurrent pregnancy loss.  Among 
the pregnancies,  110 resulted in live births regarded as normal karyotype (the Norm-group).  The other 113 
pregnancies ended in miscarriage,  and we categorized them into groups based on fetal karyotype,  determined 
by chorionic villus sampling: the Misc-NK (normal karyotype) group,  n = 35 euploid cases; the Misc-CA1 
(chromosomal abnormality) group,  n = 18 cases of aneuploidy with trisomies 13/18/21,  Turner’s syndrome,  or 
Klinefelter’s syndrome; and the Misc-CA2 subgroup,  n = 60 cases of other aneuploidies excluding those in the 
Misc-CA1 group.  We compared the groups’ regression line slopes and intercepts for FHR by an analysis of 
covariance.  The FHRs of the Norm,  Misc-NK and Misc-CA1 groups increased from 36 to 49 days after fertil-
ization,  but did not significantly differ across these groups.  The Misc-CA2 group’s FHR did not increase and 
significantly differed from the other three groups (p< 0.01).  These results suggest that the absence of an increase 
in FHR in early pregnancy may indicate the presence of chromosomal abnormalities causing miscarriage.
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patient’s consent.
However,  if this test cannot be performed for any 
reason (e.g.,  acute complete abortion),  no information 
can be obtained about fetal chromosomal abnormali-
ties.  In this study,  we retrospectively compared euploid 
and aneuploid pregnancies to evaluate differences in 
fetal heart rate (FHR) patterns,  and we investigated the 
possibility of using FHR patterns to predict the presence 
of fetal chromosomal abnormalities.
Patients and Methods
Management of RPL. At our hospital,  outpa-
tients with RPL are examined for risk factors of miscar-
riage.  Screening tests include the measurement of anti- 
phospholipids (lupus anticoagulant,  anti-cardiolipin 
IgG antibody,  anti-cardiolipin IgM antibody,  anti-β2 
glycoprotein-I antibody,  and anti-thrombin antibody),  
prolactin,  thyroid-stimulating hormone,  hemoglobin 
A1c,  and coagulation factors (protein S antigen levels 
and activity,  protein C antigen levels and activity,  and 
factor XII).  Based on the results of these tests,  we 
develop a treatment plan for subsequent pregnancies in 
accordance with the ASRM guidelines [5] and the pro-
posal from the study group of the Japanese Ministry of 
Health,  Labor and Welfare (available at: <Fuiku.jp/
common/teigen001.pdf> in Japanese).  When miscar-
riages occur despite our management,  we conduct a 
chorionic villus chromosomal analysis to ascertain the 
cause of pregnancy loss after informing the patient of 
the potential benefits and risks of the procedure and 
obtaining her consent.
Chorionic villus chromosomal analysis. We ret-
rospectively analyzed the cases of 113 women with sin-
gleton pregnancies who were managed for RPL and 
underwent a chorionic villus chromosomal analysis 
after miscarriage at Okayama University Hospital 
during the period from January 2010 to April 2016.  The 
median maternal age was 35.5 years (range 25-44 years).  
The chorionic villus chromosomal analyses were per-
formed by SRL,  Inc.  (Tokyo,  Japan) before January 
2014 and by LabCorp Japan (Tokyo,  Japan) thereafter.  
A total of 110 women with RPL and subsequent normal 
deliveries from January 2010 to September 2010 were 
also analyzed as a control group.  The median maternal 
age of the control group was 35.0 years (range 21-41 
years).
We divided the cases into 4 groups based on their 
pregnancy outcomes and chorionic villus chromosomal 
analysis results: the Norm-group,  110 normal deliver-
ies with no anomalies and regarded as euploid; the 
Misc-NK (normal karyotype) group,  35 miscarriages 
with normal karyotype; and the Misc-CA (chromo-
somal abnormality) group,  78 miscarriages with chro-
mosomal anomalies,  subdivided into the Misc-CA1 
group,  comprising the 18 cases of aneuploidy with rela-
tively higher possibilities of live birth (trisomies 
13/18/21,  Turner’s syndrome,  and Klinefelter’s syn-
drome),  and the Misc-CA2 group,  the other 60 cases of 
aneuploidy causing miscarriage (triploid,  tetraploid,  
and autosomal chromosome trisomy other than triso-
mies 13/18/21).
Our study was based on a retrospective review of 
patient data.  We conducted this study under the 
approval of the local institutional review board of our 
university (No. 1507-040).  The need for informed con-
sent was waived due to the retrospective nature of the 
study,  and the details of the study are outlined in a pub-
lication on the website of our department <http://www.
okayama-u-obgyn.jp/torikumi/rinri_research.html>,  
accessed March 2016
FHR analysis. To investigate the relationship 
between FHR and karyotype,  we analyzed the cases of 
the patients whose pregnancies ended in miscarriage 
after the fetal heartbeat was identified,  which included 
patients in the Misc-NK group,  Misc-CA1 subgroup,  
and Misc-CA2 subgroup (Table 1).
We used fertilization age in days for comparison in 
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Table 1　 Types of miscarriage and karyotypes
Group
Pre-identiﬁcation 
of fetal heartbeat 
(only the gesta-
tional sac was 
identiﬁed) n＝34
Post-identiﬁcation 
of fetal heartbeat 
n＝79
Misc-NK n＝35 13 (37.1%) 22 (62.9%)
Misc-CA n＝78 21 (26.9%) 57 (73.0%)
Misc-CA1 n＝18 2 (11.1%) 16 (88.9%)
Misc-CA2 n＝60 19 (31.7%) 41 (68.3%)
Misc-NK,  miscarriages with a normal karyotype; Misc-CA1,  mis-
carriages with trisomies 13/18/21,  Turnerʼs syndrome,  or Klinefelterʼs 
syndrome; Misc-CA2,  miscarriages with triploid,  tetraploid,  and 
autosomal chromosome trisomies other than trisomies 13/18/21.  
There were no marked diﬀerences in the rate of conﬁrmed fetal 
heartbeat among these 3 groups.
this study,  calculated as the time from ovulation to fer-
tilization; this age is 14 days less than the gestational 
age.  We collected data from day 28 after fertilization 
(DAF 28) to DAF 49 because the FHR increase follows 
a linear regression during this period [7].
FHRs were measured using transvaginal ultraso-
nography with a 3.5-MHz transducer (ALOKA,  Tokyo,  
Japan) during weekly check-ups.  The basal body tem-
perature was recorded in most of the patients.  We thus 
believe that our estimates of fetal gestational age are 
accurate and reliable.
Statistical analysis. Patient characteristics were 
compared using the Mann-Whitney U-test.  The regres-
sion lines for the FHR of each group from DAF 28 to 
DAF 49 were calculated,  and the slope and the inter-
cept of the regression lines were compared by an analy-
sis of covariance.  SPSS software ver. 21 (IBM Japan,  
Tokyo,  Japan) was used to analyze these results.  Values 
of p < 0.05 were considered significant.
Results
Chorionic villus chromosomal analysis. Fetal 
chromosomal abnormality was identified in 78 (69.0%) 
of the 113 patients who underwent a chorionic villus 
chromosomal analysis.  Among the 34 cases in which 
only the gestational sacs were confirmed and fetal 
heartbeats were unconfirmed,  chromosomal abnor-
mality was identified in 21 (61.8%).  Among all 35 cases 
of euploidy (the Misc-NK group),  the fetal heartbeat 
could be detected in 22 (62.9%).  Among the 78 cases of 
aneuploidy (Misc-CA1 + CA2 groups),  we detected fetal 
heartbeats in 57 (73.0%) (Table 1).  There was no signif-
icant difference between the Misc-NK group and Misc- 
CA group in the rate of fetal heartbeat confirmation.
Among the cases with a confirmed fetal heartbeat,  
there were no significant differences in age,  body mass 
index,  or past history of live births among the groups 
and controls.  However,  there was a marked difference 
in the history of miscarriage,  with a significantly 
greater number of miscarriages in the Misc-NK group 
compared to the patients in the Norm-group,  the 
Misc-CA1 group,  and the Misc-CA2 group (p < 0.05) 
(Table 2).
FHR before miscarriage. The FHRs of each group 
at DAF 28-49 (6-9) weeks of gestation are shown in 
Fig. 1.  The regression line equations for each group 
were as follows,  where y = FHR (bpm) and x = days after 
fertilization (DAF):
Norm-group: y = 3.664x − 5.896; n = 253,  r = 0.862;  
p < 0.001 (Fig. 1A)
Misc-NK group: y =3.898x−3.306; n=31,  r=0.855;  
p < 0.001 (Fig. 1B)
Misc-CA1 group: y=3.812x−4.682; n=32,  r=0.835;  
p < 0.001 (Fig. 1C)
Misc-CA2 group : y = −0.172x + 119.3 ; n = 46,  
r = 0.0346; p > 0.1 (Fig. 1D).
The results of the analysis of covariance revealed that the 
FHR did not significantly differ across the Norm-group,  
the Misc-NK group,  and the Misc-CA1 group.  The 
Misc-CA2 group significantly differed from the other 
three groups (p < 0.01).
Based on the 95% confidence interval of the Norm-
group and the regression line of the Misc-CA2 group 
(Fig. 1D),  after DAF 35.70,  the regression line of the 
Misc-CA2 group diverged from the 5th percentile 
boundary of the normogram without increasing in 
accordance with the DAF.  Thus,  an FHR slower than 
the 5th percentile boundary of the normogram (Norm-
group) could be used to predict the Misc-CA2 designa-
tion with a sensitivity value of 0.543 and specificity 
value of 0.922.
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Table 2　 Patient characteristics in cases with conﬁrmed fetal heartbeat; median (min.－max.)
Group Norm  n＝110 Misc-NK  n＝22 Misc-CA1  n＝16 Misc-CA2  n＝41 p-value
Age,  yrs (range) 35.5 (21-41) 35.0 (28-39) 34.0 (25-44) 37.0 (25-44) n.s.
BMI (range) 20.9 (16.0-33.0) 21.5 (16.6-31.0) 20.0 (17.5-28.3) 22.3 (16.9-28.3) n.s.
Miscarriages (no.) 2.0 (1-6) 3.0 (2-8)＊ 2.0 (1-5) 2.5 (2-5) ＜0.05
Live births (no.) 0 (0-2) 0 (0-1) 0 (0-1) 0 (0-1) n.s.
There were no signiﬁcant diﬀerences in age,  body mass index (BMI),  or past history of live birth across the Norm,  Misc-NK,  and Misc-CA 
groups.  ＊The Misc-NK group signiﬁcantly diﬀered from the 2 other groups in history of miscarriage.  The Mann-Whitney U-test was used to 
compare the data.
Discussion
The novel findings of this study are,  first,  that the 
FHRs of euploidy and aneuploidy with relatively higher 
possibilities of live birth (trisomies 13/18/21,  Turner’s 
syndrome,  and Klinefelter’s syndrome) increase simi-
larly to the FHRs of livebirths until DAF 49.  Second,  
the FHRs of the present aneuploid cases causing mis-
carriage (triploid,  tetraploid,  and autosomal chromo-
some trisomy other than trisomies 13/18/21) did not 
increase compared with those of the livebirths between 
DAF 36 and 49.
For RPL patients who experience a miscarriage,  
regardless of the treatment that was indicated by 
screening tests,  identifying whether the miscarriage 
was caused by fetal aneuploidy or other maternal risk 
factors is vital to planning the next treatment.  When a 
miscarriage with a normal fetal karyotype occurs,  a 
step-up of therapy for RPL is considered.  Currently,  
the only method used to definitively diagnose the fetal 
chromosomal karyotype is a chorionic villus chromo-
somal analysis,  which after a miscarriage is performed 
64 Sakamoto et al. Acta Med.  Okayama　Vol.  72,  No.  1
Fe
ta
l h
ea
rt 
ra
te
 (
bp
m
)
Days after fertilization
200
160
120
80
40
28 35 42 49
Fe
ta
l h
ea
rt 
ra
te
 (
bp
m
)
Days after fertilization
200
160
120
80
40
28 35 42 49
Fe
ta
l h
ea
rt 
ra
te
 (
bp
m
)
Days after fertilization
200
160
120
80
40
28 35 42 49
Fe
ta
l h
ea
rt 
ra
te
 (
bp
m
)
Days after fertilization
200
160
120
80
40
28 35 42 49
A B
C D
Fig. 1　 Change in fetal heart rate (FHR) and regression line of each group.  In all graphs,  double lines indicate the regression line,  and 
dotted lines indicate the 95%CI.  A,  FHRs of live births without anomaly (Norm-group).  The change in FHR and the regression line of live 
births without anomaly between 28-49 days of gestation are shown.  The regression line equation was y=3.664x－5.896 (n=253,  
R2 =0.7443; y= fetal heartbeat [bpm],  x=days after fertilization); B,  FHRs of the pregnancies with normal karyotypes that ended in miscar-
riage (Misc-NK group).  The regression line equation was y=3.898x－3.306 (n=31,  R2 =0.7317); C,  FHRs of the pregnancies with triso-
mies 13/18/21,  Turnerʼs syndrome,  or Klinefelterʼs syndrome that ended in miscarriage (Misc-CA1 group).  The regression line equation 
was y=3.812x－4.682 (n=32,  R2 =0.6979); D,  FHRs in the pregnancies with aneuploidy including triploid,  tetraploid,  and autosomal 
chromosome trisomies causing miscarriage (Misc-CA2 group).  The regression line equation was y=－0.1721x＋119.3 (n=46,  
R2 =0.001200).  The coordinates of the intersection (◎) of the regression line and dotted lines indicate that the 95%CI of the Norm-
group=35.70－113.2.
mainly with metaphase karyotyping.  This method gives 
information on both the chromosome number and 
arrangement; however,  it also has several limitations.  
Because of the requirement for tissue culture,  the cho-
rionic villi tissue must be obtained by intrauterine sur-
gery without bacterial or maternal cell contamination.  
Discharged chorionic villi have been analyzed with 
microarray-based comparative genomic hybridization 
(array-CGH) [8].  However,  this technique is expensive 
and not yet standardized.  Moreover,  the analysis of 
cases in which no tissue is collected (e.g.,  complete 
abortion) remains impossible.
At present,  health insurance in Japan does not cover 
chorionic villus chromosomal analyses with either 
metaphase karyotyping or array-CGH,  which are 
expensive for the average patient.  We therefore investi-
gated the possibility of the FHR measured ultrasono-
graphically to serve as a predictor of fetal karyotype.  
There were no notable differences in the rate of fetal 
heartbeat confirmation between the normal and abnor-
mal fetal karyotypes,  thus suggesting that the confir-
mation of fetal heartbeat does not exclude fetal aneu-
ploidy.
In the management of patients with RPL,  we 
observed 2 typical FHR patterns that characterized 
miscarriages after the identification of fetal heart move-
ment.  In the first pattern,  the FHR increases normally 
and stops abruptly.  In the second pattern,  the FHR 
does not demonstrate a normal pattern of increase and 
eventually ends in fetal death.  We focused on the rela-
tionship between these FHR patterns and the fetal 
karyotype.  A normal fetal heartbeat is usually con-
firmed around the sixth week of gestation and increases 
steadily to approx.  180 bpm at the ninth week of gesta-
tion [9 , 10].  Although a slow FHR at the seventh week 
of gestation or earlier is associated with a high risk of 
first trimester death [11 ,12],  it remains unclear whether 
fetal aneuploidy is the reason for these fetal deaths.  Our 
present findings provide the first evidence that one pos-
sible reason for first-trimester deaths with a slow FHR 
may be fetal aneuploidy.
We divided the present aneuploid cases into 2 
groups,  i.e.,  those with trisomies 13/18/21,  Turner’s 
syndrome,  or Klinefelter’s syndrome,  and those with 
other aneuploidies.  The following rates of miscarriage 
have been reported in fetuses with trisomies 13/18/21 
and 45, X: 79% for trisomy 21,  94% for trisomy 18,  
98% for trisomy 13,  and 99.7% for 45, X [13].  Live 
deliveries of trisomies 13/18/21,  45, X,  and 47, XXY 
are not rare.  By contrast,  the live birth of triploid 
babies is extremely rare [14 , 15].  Almost all triploid,  
tetraploids,  and autosomal chromosome trisomies other 
than trisomies 13/18/21 end in miscarriage.
Our analyses demonstrated that the pattern of FHR 
increase in miscarried fetuses with euploidy (the 
Misc-NK group) was not significantly different from 
that of the group with normal live births (the Norm-
group).  In most of the samples,  the FHRs of the 
Misc-NK group were located mainly within the 95%CI 
of normal deliveries.  Even with the chromosomal aber-
rations,  the FHR pattern of our Misc-CA1 cases was 
also not significantly different from that of the Norm-
group.  By contrast,  the regression line of FHR in the 
Misc-CA2 group differed significantly from that of the 
Norm-group.  No increase in the FHR with DAF was 
observed,  and an FHR slower than the 5th percentile 
boundary of normal live births could be used to predict 
the existence of aneuploidy leading to miscarriage with 
0.543 sensitivity and 0.922 specificity.
Notably,  we cannot conclude that a miscarriage with 
a normal FHR is due to maternal factors and that the 
fetus was euploid.  The possibility that a miscarriage 
may be due to trisomies 13/18/21,  45, X,  or 47, XXY 
cannot be ruled out.  Even in the fetal aneuploidy caus-
ing miscarriages,  45.6% of the cases had a normal FHR.  
While our results suggest a relationship between slow 
FHR and fetal aneuploidy,  no conclusions can be drawn 
regarding normal FHR and fetal euploidy.
This study also has some limitations.  The patients 
with live births were patients who had been previously 
treated for RPL at our hospital; they were not com-
pletely healthy controls.  Tezuka et al.  reported that the 
regression equation for normal embryos from 36-38 
days to 60-62 days of gestation is as follows: heart 
rate = 3.850 × gestational days (days after last menses) 
− 54.64 (R2 = 0.908,  n = 347) [7].  We recalculated our 
data from the 110 patients in the Norm-group with the 
same method and determined a regression equation of 
heart rate = 3.767 × gestational days (days after last men-
ses) − 56.10 (R2 = 0.744).  Therefore,  we believe that 
there is little difference between the FHRs in the healthy 
controls and the 110 controls in this study.
In conclusion,  our findings indicate that the absence 
of a normal increase in FHR between DAF 36 and 49 
may be useful in predicting a miscarriage that is due to 
fetal chromosomal aberrations.  The results of this study 
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may be useful for the estimation of fetal aneuploidy due 
to miscarriage with FHR when a chorionic villus chro-
mosomal analysis is not feasible.
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